拉脱维亚 - 拉脱维亚文 - Pārtikas un veterinārais dienests, Zemkopības ministrija

olimp laboratories sp. z.o.o. - kapsula

欧盟 - 拉脱维亚文 - EMA (European Medicines Agency)

samsung bioepis nl b.v. - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastiski līdzekļi - onbevzi in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. onbevzi in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer. papildinformāciju par cilvēka epidermas augšanas faktora 2 receptora (her2) statusu, lūdzu, skatiet 5. sadaļā. onbevzi in combination with capecitabine is indicated for first-line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with onbevzi in combination with capecitabine. sīkāku informāciju par her2 statusu, lūdzu, skatiet 5. sadaļā. onbevzi, in addition to platinum-based chemotherapy, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-small cell lung cancer other than predominantly squamous cell histology. onbevzi, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. onbevzi in combination with interferon alfa-2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. onbevzi, in combination with carboplatin and paclitaxel is indicated for the front-line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. onbevzi, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. onbevzi, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. onbevzi, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

欧盟 - 拉脱维亚文 - EMA (European Medicines Agency)

laboratoires smb s.a. - fenofibrate, pravastatin - dislipidēmijas - lipīdu modificējoši aģenti - pravafenix ir norādīts, par attieksmi pret augsto koronāro sirds-slimības (chd)-riska pieaugušiem pacientiem ar jaukto dyslipidaemia raksturo augsta triglicerīdu un zema hdl-cholesterol (c) līmeņiem, kuru ldl c līmenis ir pietiekami kontrolēta vienlaikus uz ārstēšana ar monoterapiju pravachol 40 mg.

拉脱维亚 - 拉脱维亚文 - Zāļu valsts aģentūra

uab valentis, lithuania - vilkābeļcu augļcu šķidrais ekstrakts - pilieni iekšķīgai lietošanai, šķīdums

拉脱维亚 - 拉脱维亚文 - Zāļu valsts aģentūra

uab valentis, lithuania - vilkābeļcu tinktūbra - pilieni iekšķīgai lietošanai, šķīdums

拉脱维亚 - 拉脱维亚文 - Pārtikas un veterinārais dienests, Zemkopības ministrija

lavet pharmaceuticals ltd., ungārija - doxycyclin hyclate - pulveris iekšķīgi lietojama šķīduma pagatavošanai - cūkas; tītari; vistas

拉脱维亚 - 拉脱维亚文 - Zāļu valsts aģentūra

unimed pharma spol. s r.o., slovakia - brimonidīna tartrāts - acu pilieni, šķīdums - 2 mg/ml

拉脱维亚 - 拉脱维亚文 - Zāļu valsts aģentūra

pharmaceutical works polpharma sa, poland - diklofenaka nātrija sāls - ilgstošās darbības tabletes - 100 mg

拉脱维亚 - 拉脱维亚文 - Zāļu valsts aģentūra

gedeon richter plc., hungary - escitaloprāms - apvalkotās tabletes - 10 mg

拉脱维亚 - 拉脱维亚文 - Zāļu valsts aģentūra

sopharma ad, bulgaria - pyridoxini hydrochloridum - Šķīdums injekcijām - 100 mg/2 ml